Evidence map›Paper›PMID 28626793›Full record

ArticleACS biomaterials science & engineering2016

Acidic pH-targeted chitosan capped mesoporous silica coated gold nanorods facilitate detection of pancreatic tumors via multispectral optoacoustic tomography.

Matthew R Zeiderman, Desiree E Morgan, John D Christein, William E Grizzle, Kelly M McMasters, Lacey R McNally

Open access · greenAbstract read
In one paragraph

Article in ACS biomaterials science & engineering, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
5.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 79 citations in OpenAlex.

  1. Assessment of Breast Tumors Using Multispectral Optoacoustic Tomography in a Surgical Setting.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2025
    Trial
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Matthew R ZeidermanUniversity of Louisville, School of Medicine, Louisville KY, 40202, USA.
Desiree E MorganUniversity of Alabama at Birmingham, School of Medicine, Birmingham, AL, 35294, USA.
John D ChristeinUniversity of Alabama at Birmingham, School of Medicine, Birmingham, AL, 35294, USA.
William E GrizzleUniversity of Alabama at Birmingham, School of Medicine, Birmingham, AL, 35294, USA.
Kelly M McMastersUniversity of Louisville, School of Medicine, Louisville KY, 40202, USA.
Lacey R McNallyUniversity of Louisville, School of Medicine, Louisville KY, 40202, USA.
University of Alabama at Birmingham · USUniversity of Louisville · US

Funding

XRAY CRYSTALLOGRAPHYP30CA013148 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Robert S Welner · 1985 to 2026
$165.9M
UAB / UMN SPORE in Pancreatic CancerP50CA101955 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BUCHSBAUM, DONALD J · 2010 to 2014
$11.1M
KiSS1 treatment of pancreatic adenocarcinomaR00CA139050 · NCI · UNIVERSITY OF LOUISVILLE · PI MCNALLY, LACEY R · 2011 to 2013
$710k
NCI NIH HHS P30 CA013148NCI NIH HHS P50 CA101955NCI NIH HHS R00 CA139050
6 · The paper itself

Abstract

We present a cancer nanomedicine based on acidic pH targeted gold nanorods designed for multispectral optoacoustic tomography (MSOT). We have designed gold nanorods coated with mesoporous silica and subsequently capped with chitosan (CMGs). We have conjugated pH-sensitive variant 7 pHLIP peptide to the CMGs (V7-CMG) to provide targeting specificity to the acidic tumor microenvironment.

Indexed as

acidic pHactive targeted nanoparticleschitosangold nanorodmesoporous silicaMSOTmultispectral optoacoustic tomographypancreatic cancerpHLIP

Identifiers

PMID28626793
PMCPMC5470628
OpenAlexW2426023920

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.